# Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

> **NCT07507773** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 135 (estimated)

## Conditions studied

- Soft Tissue Sarcoma Adult
- Soft Tissue Sarcoma (Excluding GIST)
- Soft Tissue Sarcoma of the Trunk and Extremities
- Soft Tissue Sarcoma of the Limb

## Interventions

- **RADIATION:** Moderately hypofractionated neoadjuvant radiotherapy

## Key facts

- **NCT ID:** NCT07507773
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2032-04-01
- **Final completion:** 2035-04-01
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07507773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07507773, "Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07507773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*